Gan & Lee Pharmaceuticals.
603087
Ранг среди акций
#3011
Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused... Gan & Lee Pharmaceuticals is a biopharmaceutical enterprise primarily focused on the discovery, development, manufacturing, and marketing of insulin analogues within the Chinese market. Their diverse product portfolio encompasses injectable therapies such as Basalin (an insulin glargine), Prandilin (an insulin lispro), Prandilin 25 (another insulin lispro variant), Raplin (an insulin aspart), Raplin 30 (an insulin aspart 30 formulation), and Similin 30 (an insulin injection). Beyond diabetes treatments, the company also offers various medical devices. Established in 1998, Gan & Lee Pharmaceuticals maintains its corporate headquarters in Beijing, People's Republic of China. The organization underwent a name change in April 2005, transitioning from its former identity as Beijing Gan & Lee Biotechnology Co., Ltd.
Цена акции
$10.03
Рыночная капитализация
$5.99B
Изменение (1 день)
-3.71%
Изменение (1 год)
2.30%
Страна
CN
Торговля Gan & Lee Pharmaceuticals. (603087)
Категория
Healthcare
EPS для Gan & Lee Pharmaceuticals. (603087)
EPS по состоянию на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Gan & Lee Pharmaceuticals., текущий EPS компании (TTM) составляет 0. В конце 2026 EPS компании составлял 0, равна показателю 2026 года, равному 0.
История EPS компании Gan & Lee Pharmaceuticals. с 2013 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2025 | $0.28 | 93.61% |
| 2024 | $0.14 | 68.04% |
| 2023 | $0.08 | -174.98% |
| 2022 | $-0.11 | -127.75% |
| 2021 | $0.41 | 21.57% |
| 2020 | $0.34 | 12.22% |
| 2019 | $0.30 | 11.04% |
| 2018 | $0.27 | -18.21% |
| 2017 | $0.33 | 50.25% |
| 2016 | $0.22 | 59.66% |
| 2015 | $0.14 | 39.19% |
| 2014 | $0.10 | 35.86% |
| 2013 | $0.07 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| $8.37 | - |
US
|
|
| $6.41 | - |
FR
|
|
| - | - |
JP
|
|
| $3.32 | - |
US
|
|
| - | - |
CH
|
